APA (7th ed.) Citation

L, P. G., R, S. E. S., J, S., M, Q. P., L, G., M, C., . . . A, A. (2026). NeoProspect HER2-low: Response and Prognosis After Neoadjuvant Treatment in Patients with HER2-low Breast Cancer. Cureus, 18(2), e103076. https://doi.org/10.7759/cureus.103076

Chicago Style (17th ed.) Citation

L, Pratas Guerra, et al. "NeoProspect HER2-low: Response and Prognosis After Neoadjuvant Treatment in Patients with HER2-low Breast Cancer." Cureus 18, no. 2 (2026): e103076. https://doi.org/10.7759/cureus.103076.

MLA (9th ed.) Citation

L, Pratas Guerra, et al. "NeoProspect HER2-low: Response and Prognosis After Neoadjuvant Treatment in Patients with HER2-low Breast Cancer." Cureus, vol. 18, no. 2, 2026, p. e103076, https://doi.org/10.7759/cureus.103076.